Researcher
Tim Lammens
- Keywords:acute myeloid leukemi, inherited predisposition for cancer, asparaginase, neuroblastoma, juvenile myelomonocytic leukemia, pediatric oncology
- Disciplines:Molecular and cell biology not elsewhere classified, Oncology not elsewhere classified, Nursing, Genomics, Pediatrics
Affiliations
- Department of Internal Medicine and Pediatrics (Department)
Member
From1 Oct 2018 → Today - Department of Pediatrics and medical genetics (Department)
Member
From1 Jun 2009 → 30 Sep 2018 - Department of Plant Biotechnology and Bioinformatics (Department)
Member
From1 May 2006 → 31 Jan 2009
Projects
1 - 7 of 7 results
- Preclinical study of TARP-directed cellular and nanobody therapy in pediatric AML: improving survival and quality-of-lifeFrom1 Nov 2020 → TodayFunding: Nonprofit institution or equivalents
- Minimal residual disease targeting in T-cell acute lymphoblastic leukemiaFrom1 Oct 2020 → TodayFunding: BOF - postdoctoral mandates
- Predisposition in a family with two pediatric patients with Hodgkin lymphoma Non-BurkettFrom1 Jun 2016 → 31 May 2018Funding: Foundations, funds and other with scientific goal
- Research Assignment dr. Tim Lammens ihkv the ongoing clinical-translational research at the department of Pediatric Hematology-Oncology and Stem Cell TransplantationFrom1 Jun 2015 → 30 Sep 2019
- Evaluation of the prognostic value of the leukemic stem cell (LSC) and pre-leukemic hematopoietic stem cell (pre-L HSC) for minimal residual disease monitoring and clinical management of pediatric acute myeloid leukemia patientsFrom1 Jan 2015 → 31 Dec 2018
- The role of non-coding RNA in juvenile myelomonocytic leukemiaFrom1 Jan 2013 → 31 Dec 2015Funding: Foundations, funds and other with scientific goal
- The role of non-coding RNA in juvenile myelomonocytic leukemiaFrom15 Dec 2012 → 31 Dec 2013Funding: Foundations, funds and other with scientific goal
Publications
1 - 10 of 103 results
- Circulating non-coding RNAs in head and neck cancer : roles in diagnosis, prognosis, and therapy monitoring(2021)
Authors: Araceli Diez-Fraile, Joke De Ceulaer, Charlotte Derpoorter, Christophe Spaas, Tom De Backer, Philippe Lamoral, Johan Abeloos, Tim Lammens
Number of pages: 1 - Long non-coding RNAs as novel therapeutic targets in juvenile myelomonocytic leukemia(2021)
Authors: Mattias Hofmans, Tim Lammens, Barbara Depreter, Ying Wu, Miriam Erlacher, Aurélie Caye, Hélène Cavé, Christian Flotho, Valerie de Haas, Charlotte M. Niemeyer, et al.
Number of pages: 1 - CircRNAs dysregulated in juvenile myelomonocytic leukemia : CircMCTP1 stands out(2021)
Authors: Anna Dal Molin, Mattias Hofmans, Enrico Gaffo, Alessia Buratin, Hélène Cavé, Christian Flotho, Valerie de Haas, Charlotte M. Niemeyer, Jan Stary, Pieter Van Vlierberghe, et al.
Number of pages: 1 - Aging of preleukemic thymocytes drives CpG island hypermethylation in T-cell acute lymphoblastic leukemia(2020)Volume: 136
Authors: Juliette Roels, Morgan Thénoz, Bronislawa Szarzynska, Mattias Landfors, Stien De Coninck, Lisa Demoen, Lien Provez, Anna Kuchmiy, Steven Strubbe, Lindy Reunes, et al.
Number of pages: 1 - The altered transcriptome of pediatric myelodysplastic syndrome revealed by RNA sequencing(2020)
Authors: L Zubovic, S Piazza, T Tebaldi, L Cozzuto, G Palazzo, V Sidarovich, V De Sanctis, R Bertorelli, Tim Lammens, Mattias Hofmans, et al.
Number of pages: 1 - The EMT modulator SNAI1 contributes to AML pathogenesis via its interaction with LSD1(2020)
Authors: Catherine L. Carmichael, Jueqiong Wang, Thao Nguyen, Oluseyi Kolawole, Aissa Benyoucef, Charlotte De Mazière, Anna Milne, Sona Samuel, Kevin Robert Gillinder, Soroor Hediyeh-zadeh, et al.
Pages: 957 - 973 - Aging of preleukemic thymocytes drives CpG island hypermethylation in T-cell acute lymphoblastic leukemia(2020)
Authors: Juliette Roels, Morgan Thénoz, B Szarzynska, M Landfors, Stien De Coninck, Lisa Demoen, Lien Provez, Anna Kuchmiy, Steven Strubbe, Lindy Reunes, et al.
Pages: 274 - 289 - Retrospective analysis of the incidence and characteristics of paediatric myelodysplastic syndrome and juvenile myelomonocytic leukaemia in Belgium(2020)
Authors: Lindsey De Smaele, Mattias Hofmans, Tim Lammens, A Van Damme, Jutte van der Werff ten Bosch, A Ferster, Joris Verlooy, C Chantrain, Jan Philippé, Nadine Van Roy, et al.
Pages: 233 - 239 - Leukaemic stem cells in AML : where are we now? An update on recent findings and detection(2020)
Authors: Barbara Depreter, Barbara De Moerloose, Jan Philippé, Tim Lammens
Pages: 246 - 252 - Targeting cytokine- and therapy-induced PIM1 activation in preclinical models of T-cell acute lymphoblastic leukemia and lymphoma(2020)
Authors: Renate De Smedt, Julie Morscio, Lindy Reunes, Juliette Roels, Valentina Bardelli, Béatrice Lintermans, Wouter Van Loocke, Afonso Almeida, Laurence C. Cheung, Rishi S. Kotecha, et al.
Pages: 1685 - 1695